The 2 factors that will determine if Omicron is a true threat, according to Pfizer’s top scientist

Hello,

Welcome to Insider Healthcare. I’m healthcare editor Leah Rosenbaum, and today in healthcare news:


If you’re new to this newsletter, sign up here. Comments, tips? Email me at [email protected] or tweet @leah_rosenbaum. Let’s get to it…


A headshot of Mikael Dolsten, Pfizer's chief scientific officer
Mikael Dolsten, ‘s chief scientific officer Pfizer

Pfizer’s top scientist Mikael Dolsten tells us the 2 factors that will determine if Omicron is a true threat and shares Pfizer’s worst-case-scenario plan

Read more>>


An employee at the Afrigen biotechnology company and Vaccine Hub facility, works in a laboratory in Cape Town, on October 05, 2021.
A laboratory worker in Cape Town, South Africa, on October 5, 2021. Rodger Bosch/AFP via Getty Images

Southern Africa is not a hotbed of variants — it’s just very good at sequencing and spotting them

Check it out>> 


Capsules of molnupiravir, an antiviral drug developed by Merck and Ridgeback Biotherapeutics that could treat COVID-19
Molnupiravir is an experimental oral antiviral developed by and Ridgeback Biotherapeutics that could treat COVID-19 Merck

An FDA expert panel narrowly supports the first COVID-19 pill but suggests restrictions on its use driven by safety concerns

Dive in>>


More stories we’re reading:


-Leah